as on November 7, 2025 at 2:29 am IST
Day's Low
Day's High
2.53%
Downside
2.00%
Upside
52 Week's Low
52 Week's High
61.65%
Downside
205.26%
Upside
Check Bioage Labs Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$268.9M
EPS (TTM)
-2.0145
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-35.88%
Compare market cap, revenue, PE, and other key metrics of Bioage Labs Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $268.9M | NA | NA | 0.00% | |
| BUY | $19.5B | NA | 17.21 | 40.65% | |
| BUY | $41.9B | NA | 21.65 | 13.81% | |
| BUY | $15.3B | 60.68% | 36.69 | 15.95% | |
| BUY | $53.4B | -29.36% | 20.77 | 27.83% |
The Bioage Labs Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bioage Labs Inc. investment value today
Current value as on today
₹41,457
Returns
Returns from Bioage Labs Inc. Stock
Dollar Returns*
₹5,036 (+5.04%)
Search interest for Bioage Labs Inc. Stock has increased by 182% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:182% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, BIOA stock has moved up by 33.9%
Against Peers
![]()
In the last 1 year, Neurocrine Biosciences Inc. has given 24.0% return, outperforming this stock by 87.6%
| Organisation | Bioage Labs Inc. |
| Headquarters | 1445A South 50th Street, Richmond, CA, United States, 94804 |
| CEO | Dr. Kristen Fortney Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Kristen Fortney Ph.D. | Co-Founder, CEO, President, Treasurer, Secretary & Director |
Dr. Eric Morgen M.D. | Co-Founder, COO & Director |
Dr. Paul D. Rubin M.D. | Chief Medical Officer & Executive VP of Research |
Dr. Dov A. Goldstein M.B.A., M.D. | Chief Financial Officer |
Mr. Rusty Montgomery Ph.D. | Senior Vice President of Research |
Ms. Julie Gammelgard | Senior Vice President of People |
Dr. Peng Leong M.B.A., Ph.D. | Chief Business Officer & Therapeutic Area Head of Brain Aging |
Bioage Labs Inc. share price today is $7.51 as on at the close of the market. Bioage Labs Inc. share today touched a day high of $7.66 and a low of $7.32.
Bioage Labs Inc. share touched a 52 week high of $22.93 on and a 52 week low of $2.88 on . Bioage Labs Inc. stock price today i.e. is closed at $7.51,which is 67.24% down from its 52 week high and 160.76% up from its 52 week low.
Bioage Labs Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Bioage Labs Inc. (BIOA) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Bioage Labs Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bioage Labs Inc. share’s latest price of $7.51 as on November 7, 2025 at 2:29 am IST, you will get 1.3316 shares of Bioage Labs Inc.. Learn more about
fractional shares .